Intensity Therapeutics, Inc.

NasdaqCM:INTS Stock Report

Market Cap: US$15.8m

Intensity Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of INTS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,569,3574.28%
Private Companies2,712,7434.52%
Institutions4,676,9577.79%
General Public50,105,90883.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 319.4%.

Top Shareholders

Top 25 shareholders own 16.33% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.36%
Lewis Bender
2,020,000US$533.0k0%no data
3.36%
Vcapital Intensity, Llc
2,015,871US$531.9k0%no data
2.06%
Armistice Capital LLC
1,237,113US$326.4k0%0.01%
1.16%
Levy Family Partners, LLC
696,872US$183.9k0%no data
1.08%
Sapient Capital, LLC
650,151US$171.6k-33.4%no data
1.08%
The Vanguard Group, Inc.
649,084US$171.3k154%no data
0.83%
Rothschild Wealth LLC
495,910US$130.9k3.06%0.02%
0.77%
Geode Capital Management, LLC
460,248US$121.4k77.8%no data
0.72%
Leonard Batterson
435,342US$114.9k0%no data
0.42%
Mesirow Financial Investment Management, Inc.
251,000US$66.2k25.5%no data
0.26%
Legacy Advisors, LLC
153,447US$40.5k0%0.01%
0.22%
Brown Advisory Incorporated
130,072US$34.3k0%no data
0.14%
John Wesolowski
85,354US$22.5k11.7%no data
0.13%
Stonebridge Financial Group, LLC
77,377US$20.4k42.3%no data
0.11%
Warberg Asset Management LLC
69,000US$18.2k15%0.08%
0.1%
Jane Street Group, LLC
62,755US$16.6k0%no data
0.094%
Sigma Planning Corporation
56,432US$14.9k-18.4%no data
0.079%
IHT Wealth Management LLC
47,483US$12.5k0%no data
0.069%
EWA, LLC
41,354US$10.9k115%no data
0.063%
William Blair Investment Management, LLC
37,805US$10.0k0%no data
0.053%
One Charles Private Wealth Services, LLC
31,800US$8.4k0%no data
0.048%
Joseph Talamo
28,661US$7.6k102%no data
0.043%
Virtu Financial, Inc.
25,975US$6.9k89.6%no data
0.042%
UBS Asset Management AG
25,397US$6.7k-81.4%no data
0.041%
Scientech Research LLC
24,726US$6.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/15 13:47
End of Day Share Price 2026/02/13 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Intensity Therapeutics, Inc. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Robert WassermanBenchmark Company
Kumaraguru RajaBrookline Capital Markets